TOP STORIES

• BUSINESS Teijin Pharma Set to Transform Biz, Weather Feburic Patent Cliff with Takeda’s DPP-4s
  April 8, 2021

• BUSINESS Astellas Ended Scholarship Donation to Clear Up Doubts on Inducing Prescriptions, No Major Issues Seen after 1 Year
  April 8, 2021

• BUSINESS Takeda Sees FY2021 as Inflection Year for Pipeline, 4 Potential Approvals from 6 Submission-Planned Assets
  April 7, 2021

• BUSINESS AstraZeneca Looks to Become Top Drug Maker in Japan by 2025
  April 7, 2021

• REGULATORY AMED to Set Up Council to Hone Academic Seeds with Industry Input
  April 7, 2021

• BUSINESS Daiichi Sankyo Looks to Rack Up Sales of 1.6 Trillion Yen in FY2025, 3 ADCs as Drivers
  April 6, 2021

• REGULATORY MHLW to Consider Ways to Address Listing Delays Linked to Off-Year Re-Pricing: Official
  April 6, 2021

• REGULATORY Nichi-Iko’s Toyama Plant Gets Back Online as Suspension Order Lifted
  April 6, 2021

• REGULATORY Ex-PMDA Inspector Urges Improvements in Japanese Inspection Systems after GMP Scandals
  April 5, 2021

• BUSINESS Takeda/CSL-Led Alliance’s COVID-19 Plasma Therapy Fails in PIII
  April 5, 2021

• BUSINESS GSK Sees Promise in Antibody Therapy against Coronavirus Variants, Looking at Japan Rollout Too
  April 2, 2021

• BUSINESS Alinamin Aims for Growth via Retail Promotion, Full Entry into Asia: President
  April 2, 2021

• BUSINESS Sandoz Shooting for Top Foreign Player in Japan Generic Market by 2023
  April 1, 2021

• BUSINESS Japan Trials Get Underway for AstraZeneca’s COVID-19 Antibody Therapy
  April 1, 2021

• ORGANIZATION Generic Industry Group Requests Blanket Manufacturing Checkups for 39 Member Firms
  March 31, 2021

• BUSINESS Nafamostat Inhalation Drug Now in Clinic for COVID-19: Daiichi Sankyo
  March 31, 2021

• REGULATORY Japan Gives Up on Setting New Generic Target by March as Manufacturing Scandals Weigh
  March 30, 2021

• REGULATORY Japan to Wade Deeper into Generic Industry Revamp in New Pharma Vision, Due Out Summer
  March 29, 2021

• REGULATORY 35.6% of Pfizer Vaccine Recipients Developed Fevers after 2nd Shot, Higher Incidence in Women: MHLW
  March 29, 2021

• REGULATORY Nichi-Iko Starting Marketing Operations from March 29
  March 29, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 102
• 103
• 104
• 105
• 106
• 107
• 108
• 109
• 110
• …
• Next ›
• 最終 »